Multiple logistic regression analysis (logistic model 3) of PML reports for treatment patterns containing methotrexate, rituximab, glucocorticoids and TNF-α inhibitors in patients with RA. This evidence concerns the gene TNF and progressive multifocal leukoencephalopathy.